根治性放疗后短期复发食管癌的手术治疗

    Surgical procedure for recurrent esophageal carcinoma after curative radiotherapy

    • 摘要: 目的:探讨根治性放疗后短期复发食管癌的合理治疗。方法:回顾性分析21例食管癌放疗后短期复发患者(手术组)的手术情况,并与22例接受保守性治疗的患者(保守治疗组)进行比较。结果:手术组有20例(95.2%)完成了肿瘤切除,术后发生低氧血症15例,肺部感染2例,吻合口瘘1例。手术组术后1、3、5年生存率分别为71.4%、33.3%和14.3%。保守治疗组术后1年生存率为45.5%,与手术组比较差异无统计学意义(P0.05);保守治疗组2年后无生存者,生存期2~17个月。肿瘤复发治疗后半年疗效满意度手术组为66.7%,明显高于保守治疗组的27.3%(P0.01)。结论:根治性放疗后短期复发食管癌的手术风险较大,手术难度增加,须仔细行围手术期准备,手术能给患者带来生存受益。

       

      Abstract: Objective: To explore a rational therapy for recurrent esophageal carcinoma after radical radiotherapy. Methods: The clinical data of 21 patients with esophageal carcinoma having received esophagectomy were analyzed and compared with those of 22 patients treated by conservative therapy. Results: Twenty cases in the surgery group( 95. 2%) underwent esophagectomy. Postoperative hyoxemia occurred in 15 cases,anastomotic leakage in 1 case and pulmonary infection in 2 cases. The 1,3 and 5-year survival rate was 71. 4%,33. 3% and 14. 3% respectively in the surgery group,while the 1-year survival rate was 45. 5% in the conservative treatment group,the difference was not significant( P 0. 05),no one in the conservative treatment group survived after 2 years,and their survival duration was 2- 17 months. The satisfaction degree half-year after the recurrence was 66. 7% in the surgery group,which was significantly higher than the 27. 3% in the conservative treatment group( P 0. 01). Conclusions: Surgery is of great risk for patients with recurrent esophageal carcinoma after curative radiotherapy,so attentive peril-operation preparation is essential. Operation may bring survival benefit to those patients.

       

    /

    返回文章
    返回